Showing results (1-10 of 133) with videos related to
Sort By:
Pageof 14
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 1, 2003
[Treatment strategy of localized prostate cancer]Osamu MaedaNihon Rinsho. Japanese Journal of Clinical Medicine|February 18, 2005
[Summary of 'General Rule for Clinical and Pathological Studies on Prostate Cancer (the 3rd Edition)']Osamu Maeda, Michiyuki UsamiWorld Journal of Gastrointestinal Oncology|August 2, 2019
Recent progress of chemotherapy and biomarkers for gastroesophageal cancerOsamu Maeda, Yuichi AndoJapanese Journal of Clinical Oncology|December 13, 2025
Efficacy and safety of immune checkpoint inhibitor rechallenge following immune-related adverse events: a reviewKazuyuki Mizuno, Osamu Maeda, Yuichi AndoJapanese Journal of Clinical Oncology|January 6, 2024
Biomarkers for immune-related adverse events in cancer patients treated with immune checkpoint inhibitorsYao Liang, Osamu Maeda, Yuichi AndoAnticancer Research|May 6, 2020
Pegylated Liposomal Doxorubicin/Oxaliplatin Chemotherapy Can Overcome Cisplatin Resistance in Spectrin αII-Overexpressing Ovarian CarcinomaOsamu Maeda, Hiroaki Kajiyama, Kiyosumi Shibata, et al.International Immunopharmacology|May 18, 2011
Dehydrocorydaline inhibits elevated mitochondrial membrane potential in lipopolysaccharide-stimulated macrophagesKazuhiro Ishiguro, Takafumi Ando, Osamu Maeda, et al.Plos One|August 11, 2025
Correction: Effects of KRAS, STK11, KEAP1, and TP53 mutations on the clinical outcomes of immune checkpoint inhibitors among patients with lung adenocarcinomaYao Liang, Osamu Maeda, Chiaki Kondo, et al.Immunology and Cell Biology|April 30, 2014
Suppressive action of acetate on interleukin-8 production via tubulin-α acetylationKazuhiro Ishiguro, Takafumi Ando, Osamu Maeda, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 1, 2011
Cutting edge: tubulin α functions as an adaptor in NFAT-importin β interactionKazuhiro Ishiguro, Takafumi Ando, Osamu Maeda, et al.Pageof 14